{"id":"W2158082603","doi":"10.2147/ijnrd.s48496","title":"Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence","year":2014,"lang":"en","type":"review","venue":"International Journal of Nephrology and Renovascular Disease","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Pazopanib; Axitinib; Temsirolimus; Sunitinib; Everolimus; Medicine; Oncology; Renal cell carcinoma; Internal medicine; Bevacizumab; Sorafenib; Intensive care medicine; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005277763,0.0005969231,0.003902548,0.001077758,0.0003778859,0.002975506,0.001733266,0.001927372,0.00953279],"category_scores_gemma":[0.01255116,0.0004137371,0.003218795,0.001458849,0.0009377974,0.002830129,0.0008698252,0.002569783,0.001154745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001199428,"about_ca_system_score_gemma":0.002619942,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001107122,"about_ca_topic_score_gemma":0.003397478,"domain_scores_codex":[0.9973946,0.0009189799,0.0007228919,0.0003470354,0.0004994363,0.0001169877],"domain_scores_gemma":[0.9837811,0.01224848,0.002387815,0.0002036485,0.00111902,0.0002598694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002483374,0.0002668551,0.001558023,0.2248038,0.003014035,0.00009865808,0.000150982,0.0004596543,0.0004468758,0.003643937,0.01060038,0.7524734],"study_design_scores_gemma":[0.001423811,0.002681436,0.008323914,0.4907337,0.02021089,0.001082511,0.0007663075,0.0005189301,0.0007646955,0.01162091,0.4617907,0.00008210407],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004492937,0.9972857,0.000093858,0.001254406,0.0001028508,0.00001485503,0.00006052806,0.000003782979,0.0007347332],"genre_scores_gemma":[0.01198417,0.9843475,0.0005911569,0.00223557,0.0004969957,0.00003901128,0.0001550495,0.000006171345,0.0001444375],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00953279,"threshold_uncertainty_score":0.03189033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0656559042160513,"score_gpt":0.3575867527509122,"score_spread":0.2919308485348608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}